Carfilzomib and Hyper-CVAD in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoma
Clinical trial NCT02293109 · COMPLETED
Trial details
- NCT number
- NCT02293109
- Sponsor
- Mehrdad Abedi, MD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-17
- Primary completion
- 2017-12-13
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.